Agenda Chronic Liver Disease 2025

Saturday, March 15, 2025

7 a.m.                 

Registration, Breakfast & View Exhibits


7:15 a.m.

Breakfast Symposium

Non-CME Activity Hosted by Madrigal


8 a.m.                 

Welcome & Introduction

Paul Pockros, MD


IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE


8:15 a.m.                           

Use of Surrogate Markers and Algorithms to Identify High Risk Patients and Optimize Outcomes

Naim Alkhouri, MD


8:45 a.m.           

Lifestyle Recommendations in Clinical Practice

Jennie Luna, MD


9:15 a.m.                           

Incretins for Patients with MASH and T2D

Kenneth Cusi, MD


10 a.m.               

Break & View Exhibits


10:30 a.m.         

Drug Development for MASH

Julio Gutierrez, MD


11:15 a.m.         

Panel Discussion/Q&A


Noon                   

Lunch


Noon

Lunch Symposium

Non-CME Activity Hosted by Gilead Sciences


EVOLVING THERAPIES FOR ADVANCED LIVER CARE


1 p.m.                 

New Guidance for Hepatitis B and C

Norah Terrault, MD         


1:30 p.m.                           

All Things Itchy: PBC, PSC, and Pruritus

Christopher Bowlus, MD


2 p.m.                

Break & View Exhibits


2:15 p.m.                           

Alcohol Hepatitis

Raymond Lee, MD


2:45 p.m.                           

Panel Discussion/Q&A  


3:15 p.m.                           

Adjourn


3:30 p.m.                           

Welcome Reception

Sunday, March 16, 2025

7 a.m.                 

Breakfast & View Exhibits


7:55 a.m.                           

Welcome & Announcements

Adam Deising, DO


ESLD, HCC AND TRANSPLANTATION


8 a.m.                 

Refractory Hepatic Encephalopathy

Sammy Saab, MD


8:30 a.m.           

Mock HCC Tumor Board

Ramsey Al-Hakim, MD

Jennifer Au, MD (Moderator)

Munveer Bhangoo, MD

Jonathan Fisher, MD

Kathryn Fowler, MD

Pierre Gholam, MD


9:30 a.m.                           

Systemic Therapies for HCC

Pierre Gholam, MD


10 a.m.         

Break & View Exhibits


10:30 a.m.         

WILLIAM S. HAUBRICH LECTURE: ASOs and siRNAs for HBV – How Do They Work and How Should We Use Them?

Jordan Feld, MD


11:30 a.m.         

Panel Discussion/Q&A


Noon                   

Final Adjournment       


**Topics, times, and speakers are subject to change